Cargando…

Active monitoring of adverse reactions following COVID-19 and other vaccinations: a feasibility study as part of the CoVaKo project

BACKGROUND: The Corona-Vakzin-Konsortium project (CoVaKo) analyses the efficacy and safety of COVID-19 vaccines in a real-world setting, as well as breakthrough infections in Bavaria, Germany. A subproject of CoVaKo aims to identify adverse reactions of the COVID-19 vaccine and compare these to adve...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeschick, Nikoletta, Warkentin, Lisette, Kühlein, Thomas, Steininger, Philipp, Überla, Klaus, Hueber, Susann, Sebastião, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250275/
https://www.ncbi.nlm.nih.gov/pubmed/35780172
http://dx.doi.org/10.1186/s40814-022-01088-y
_version_ 1784739776711098368
author Zeschick, Nikoletta
Warkentin, Lisette
Kühlein, Thomas
Steininger, Philipp
Überla, Klaus
Hueber, Susann
Sebastião, Maria
author_facet Zeschick, Nikoletta
Warkentin, Lisette
Kühlein, Thomas
Steininger, Philipp
Überla, Klaus
Hueber, Susann
Sebastião, Maria
author_sort Zeschick, Nikoletta
collection PubMed
description BACKGROUND: The Corona-Vakzin-Konsortium project (CoVaKo) analyses the efficacy and safety of COVID-19 vaccines in a real-world setting, as well as breakthrough infections in Bavaria, Germany. A subproject of CoVaKo aims to identify adverse reactions of the COVID-19 vaccine and compare these to adverse reactions of other vaccines in an online survey. In a preceding feasibility study, the study materials were tested for comprehensibility, visual design, and motivation to participate, as well as for their ability to be implemented and carried out in primary care practices and vaccination centres. METHODS: We used a mixed-methods research design. First, three focus groups consisting of general population participants were organised to evaluate the study materials and survey. Second, a test roll-out was conducted in vaccination centres and primary care practices that involved implementing and quantitatively evaluating the online survey. Third, interviews were conducted with participating general practitioners and heads of vaccination centres four weeks after the test roll-out. RESULTS: Parts of the information and registration form proved incomprehensible, specifically regarding the recruitment material and/or online survey. For example, headings were misleading given that, relative to other vaccinations, the COVID-19 vaccination was overemphasised in the title. Participants requested additional information regarding the procedure and completion time. Within 31 days, 2199 participants, who received either a COVID-19 vaccination (99%) or at least one of the control vaccinations (1%), registered for the study. Participants (strongly) agreed that the registration process was easy to understand, that the completion time was reasonable, and that the technical setup was straightforward. Physicians and heads of the vaccination centres perceived the study as easy to integrate into their workflow. The majority expressed willingness to participate in the main study. CONCLUSIONS: Our study indicated that identifying and documenting adverse reactions following vaccinations using an online survey is feasible. Testing materials and surveys provided valuable insight, enabling subsequent improvements. Participation from health professionals proved essential in ensuring the practicality of procedures. Lastly, adapting the study’s organisation to external fluctuating structures and requirements confirmed necessary for a successful implementation, especially due to dynamic changes in the nation’s COVID-19 vaccination strategies. TRIAL REGISTRATION: The trial was retrospectively registered at the “Deutsches Register Klinischer Studien” (DRKS-ID: DRKS00025881) on Oct 14, 2021. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40814-022-01088-y.
format Online
Article
Text
id pubmed-9250275
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-92502752022-07-03 Active monitoring of adverse reactions following COVID-19 and other vaccinations: a feasibility study as part of the CoVaKo project Zeschick, Nikoletta Warkentin, Lisette Kühlein, Thomas Steininger, Philipp Überla, Klaus Hueber, Susann Sebastião, Maria Pilot Feasibility Stud Research BACKGROUND: The Corona-Vakzin-Konsortium project (CoVaKo) analyses the efficacy and safety of COVID-19 vaccines in a real-world setting, as well as breakthrough infections in Bavaria, Germany. A subproject of CoVaKo aims to identify adverse reactions of the COVID-19 vaccine and compare these to adverse reactions of other vaccines in an online survey. In a preceding feasibility study, the study materials were tested for comprehensibility, visual design, and motivation to participate, as well as for their ability to be implemented and carried out in primary care practices and vaccination centres. METHODS: We used a mixed-methods research design. First, three focus groups consisting of general population participants were organised to evaluate the study materials and survey. Second, a test roll-out was conducted in vaccination centres and primary care practices that involved implementing and quantitatively evaluating the online survey. Third, interviews were conducted with participating general practitioners and heads of vaccination centres four weeks after the test roll-out. RESULTS: Parts of the information and registration form proved incomprehensible, specifically regarding the recruitment material and/or online survey. For example, headings were misleading given that, relative to other vaccinations, the COVID-19 vaccination was overemphasised in the title. Participants requested additional information regarding the procedure and completion time. Within 31 days, 2199 participants, who received either a COVID-19 vaccination (99%) or at least one of the control vaccinations (1%), registered for the study. Participants (strongly) agreed that the registration process was easy to understand, that the completion time was reasonable, and that the technical setup was straightforward. Physicians and heads of the vaccination centres perceived the study as easy to integrate into their workflow. The majority expressed willingness to participate in the main study. CONCLUSIONS: Our study indicated that identifying and documenting adverse reactions following vaccinations using an online survey is feasible. Testing materials and surveys provided valuable insight, enabling subsequent improvements. Participation from health professionals proved essential in ensuring the practicality of procedures. Lastly, adapting the study’s organisation to external fluctuating structures and requirements confirmed necessary for a successful implementation, especially due to dynamic changes in the nation’s COVID-19 vaccination strategies. TRIAL REGISTRATION: The trial was retrospectively registered at the “Deutsches Register Klinischer Studien” (DRKS-ID: DRKS00025881) on Oct 14, 2021. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40814-022-01088-y. BioMed Central 2022-07-02 /pmc/articles/PMC9250275/ /pubmed/35780172 http://dx.doi.org/10.1186/s40814-022-01088-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Zeschick, Nikoletta
Warkentin, Lisette
Kühlein, Thomas
Steininger, Philipp
Überla, Klaus
Hueber, Susann
Sebastião, Maria
Active monitoring of adverse reactions following COVID-19 and other vaccinations: a feasibility study as part of the CoVaKo project
title Active monitoring of adverse reactions following COVID-19 and other vaccinations: a feasibility study as part of the CoVaKo project
title_full Active monitoring of adverse reactions following COVID-19 and other vaccinations: a feasibility study as part of the CoVaKo project
title_fullStr Active monitoring of adverse reactions following COVID-19 and other vaccinations: a feasibility study as part of the CoVaKo project
title_full_unstemmed Active monitoring of adverse reactions following COVID-19 and other vaccinations: a feasibility study as part of the CoVaKo project
title_short Active monitoring of adverse reactions following COVID-19 and other vaccinations: a feasibility study as part of the CoVaKo project
title_sort active monitoring of adverse reactions following covid-19 and other vaccinations: a feasibility study as part of the covako project
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250275/
https://www.ncbi.nlm.nih.gov/pubmed/35780172
http://dx.doi.org/10.1186/s40814-022-01088-y
work_keys_str_mv AT zeschicknikoletta activemonitoringofadversereactionsfollowingcovid19andothervaccinationsafeasibilitystudyaspartofthecovakoproject
AT warkentinlisette activemonitoringofadversereactionsfollowingcovid19andothervaccinationsafeasibilitystudyaspartofthecovakoproject
AT kuhleinthomas activemonitoringofadversereactionsfollowingcovid19andothervaccinationsafeasibilitystudyaspartofthecovakoproject
AT steiningerphilipp activemonitoringofadversereactionsfollowingcovid19andothervaccinationsafeasibilitystudyaspartofthecovakoproject
AT uberlaklaus activemonitoringofadversereactionsfollowingcovid19andothervaccinationsafeasibilitystudyaspartofthecovakoproject
AT huebersusann activemonitoringofadversereactionsfollowingcovid19andothervaccinationsafeasibilitystudyaspartofthecovakoproject
AT sebastiaomaria activemonitoringofadversereactionsfollowingcovid19andothervaccinationsafeasibilitystudyaspartofthecovakoproject